Matches in SemOpenAlex for { <https://semopenalex.org/work/W2734974043> ?p ?o ?g. }
Showing items 1 to 70 of
70
with 100 items per page.
- W2734974043 abstract "MicroRNAs (miRs) are small endogenous RNA molecules that repress gene translation by hybridizing to 3’-UTRs of mRNAs. Accumulating evidence has shown that miRs play a critical regulatory role in the pathogenesis of ischemic stroke. MiR-15a and miR-16-1 are two highly conserved miRs, which act similarly by binding to their common mRNA targets, thus forming both a structural and functional cluster. Dysregulated plasma levels of miR-15a/16-1 have been reported in stroke patients. Inhibition of miR-15a has been shown to protect against myocardial infarction and selected by pharmaceutical companies as one of the most attractive miR-based therapeutics. Up to now, the essential role and therapeutic potential of the miR-15a/16-1 cluster in ischemic stroke are poorly understood. In this study, adult male miR-15a/16-1 knockout and wildtype mice were subjected to 45 min of middle cerebral artery occlusion (MCAO) and 72h of reperfusion. In a separate experiment, miR-15a/16-1 specific inhibitor (antagomir, 30 pmol/g) was injected into tail vein of stroke mice and the animals were allowed to survive for 72h. The neurological scores, brain infarct volume, and edema content were then evaluated and analyzed. To explore the underlying mechanism, inflammatory factors were measured by qPCR or ELISA and anti-apoptotic proteins were examined by western blotting. We found that genetic deletion of miR-15a/16-1 or intravenous delivery of miR-15a/16-1 antagomir significantly reduced cerebral infarct size, decreased brain edema and improved neurological outcomes in stroke mice. Mechanistically, treatment of miR-15a/16-1 antagomir significantly ameliorated the expression of several key inflammatory factors and increased the Bcl-2 and Bcl-w levels in the ischemic brain regions. These results demonstrated that pharmacological inhibition of miR-15a/16-1 reduces ischemic brain injury via both anti-apoptotic and anti-inflammatory mechanisms and the miR-15a/16-1 cluster is a novel therapeutic target for ischemic stroke." @default.
- W2734974043 created "2017-07-21" @default.
- W2734974043 creator A5004144742 @default.
- W2734974043 creator A5047568935 @default.
- W2734974043 creator A5051363890 @default.
- W2734974043 creator A5082857859 @default.
- W2734974043 date "2017-02-01" @default.
- W2734974043 modified "2023-09-27" @default.
- W2734974043 title "Abstract TP264: MicroRNA-15a/16-1 Antagomir Ameliorates Ischemic Brain Injury in Experimental Stroke" @default.
- W2734974043 doi "https://doi.org/10.1161/str.48.suppl_1.tp264" @default.
- W2734974043 hasPublicationYear "2017" @default.
- W2734974043 type Work @default.
- W2734974043 sameAs 2734974043 @default.
- W2734974043 citedByCount "0" @default.
- W2734974043 crossrefType "journal-article" @default.
- W2734974043 hasAuthorship W2734974043A5004144742 @default.
- W2734974043 hasAuthorship W2734974043A5047568935 @default.
- W2734974043 hasAuthorship W2734974043A5051363890 @default.
- W2734974043 hasAuthorship W2734974043A5082857859 @default.
- W2734974043 hasConcept C104317684 @default.
- W2734974043 hasConcept C126322002 @default.
- W2734974043 hasConcept C127413603 @default.
- W2734974043 hasConcept C145059251 @default.
- W2734974043 hasConcept C170493617 @default.
- W2734974043 hasConcept C182704531 @default.
- W2734974043 hasConcept C2779368916 @default.
- W2734974043 hasConcept C2780645631 @default.
- W2734974043 hasConcept C2780886150 @default.
- W2734974043 hasConcept C2780942790 @default.
- W2734974043 hasConcept C541997718 @default.
- W2734974043 hasConcept C55493867 @default.
- W2734974043 hasConcept C71924100 @default.
- W2734974043 hasConcept C78519656 @default.
- W2734974043 hasConcept C86803240 @default.
- W2734974043 hasConcept C98274493 @default.
- W2734974043 hasConceptScore W2734974043C104317684 @default.
- W2734974043 hasConceptScore W2734974043C126322002 @default.
- W2734974043 hasConceptScore W2734974043C127413603 @default.
- W2734974043 hasConceptScore W2734974043C145059251 @default.
- W2734974043 hasConceptScore W2734974043C170493617 @default.
- W2734974043 hasConceptScore W2734974043C182704531 @default.
- W2734974043 hasConceptScore W2734974043C2779368916 @default.
- W2734974043 hasConceptScore W2734974043C2780645631 @default.
- W2734974043 hasConceptScore W2734974043C2780886150 @default.
- W2734974043 hasConceptScore W2734974043C2780942790 @default.
- W2734974043 hasConceptScore W2734974043C541997718 @default.
- W2734974043 hasConceptScore W2734974043C55493867 @default.
- W2734974043 hasConceptScore W2734974043C71924100 @default.
- W2734974043 hasConceptScore W2734974043C78519656 @default.
- W2734974043 hasConceptScore W2734974043C86803240 @default.
- W2734974043 hasConceptScore W2734974043C98274493 @default.
- W2734974043 hasIssue "suppl_1" @default.
- W2734974043 hasLocation W27349740431 @default.
- W2734974043 hasOpenAccess W2734974043 @default.
- W2734974043 hasPrimaryLocation W27349740431 @default.
- W2734974043 hasRelatedWork W1980494884 @default.
- W2734974043 hasRelatedWork W2052818193 @default.
- W2734974043 hasRelatedWork W2286216520 @default.
- W2734974043 hasRelatedWork W2410948106 @default.
- W2734974043 hasRelatedWork W2416872760 @default.
- W2734974043 hasRelatedWork W2613946128 @default.
- W2734974043 hasRelatedWork W3030948420 @default.
- W2734974043 hasRelatedWork W4313584969 @default.
- W2734974043 hasRelatedWork W63983557 @default.
- W2734974043 hasRelatedWork W75735400 @default.
- W2734974043 hasVolume "48" @default.
- W2734974043 isParatext "false" @default.
- W2734974043 isRetracted "false" @default.
- W2734974043 magId "2734974043" @default.
- W2734974043 workType "article" @default.